Table 2

Cox model (univariable model) and time-dependent Cox model for the risk on neo-aortic valve regurgitation

Risk factorsAR ≥moderate (n=33)AR ≥mild (n=111)
Events/totalHR (95% CI)P valueEvents/totalHR (95% CI)P value
Morphological subtype 0.02 0.009
 TGA-IVS*17/230Ref (1)65/230Ref (1)
  TGA-VSD10/892.01 (0.92 to 4.38)0.0832/891.71 (1.08 to 2.71) 0.02
  DORV-SP-VSD6/263.55 (1.38 to 9.15) 0.01 14/262.28 (1.21 to 4.28) 0.01
Gender
 Male†26/228Ref (1)72/228Ref (1)
  Female7/1170.49 (0.21 to 1.17)0.1139/1171.03 (0.67 to 1.58)0.89
Pulmonary valve
 Tricuspid‡31/324Ref (1)105/324Ref (1)
  Bicuspid2/211.16 (0.25 5.48)0.855/210.89 (0.34 to 2.30)0.49
Left ventricular OTO
 No§33/333Ref (1)106/333Ref (1)
  Yes0/12N/AN/A5/121.25 (0.48 to 3.25)0.65
Previous PAB
 No¶31/327Ref (1)103/327Ref (1)
  Yes2/182.02 (0.48 to 8.46)0.348/181.94 (0.87 to 4.33)0.11
Age ASO ≥6 months
 No**32/333Ref (1)104/333Ref (1)
  Yes1/120.83 (0.09 to 7.55)0.877/122.97 (1.10 to 8.04) 0.03
Time-dependent CoxAR ≥moderateAR ≥mild
Diameter increaseUV/MVHR (95% CI)P valueHR (95% CI)P value
Annulus (per mm)UV1.14 (1.04 to 1.25) 0.004 1.04 (0.98 to 1.10)0.16
MV1.09 (0.99 to 1.21)‡‡0.091.03 (0.97 to 1.09)† †0.31
Root (per mm)UV1.12 (1.05 to 1.21) 0.001 1.04 (1.00 to 1.10)0.07
MV1.09 (1.01 to 1.17)‡‡ 0.04 1.04 (0.99 to 1.09)† † 0.1
STJ (per mm)UV1.06 (0.94 to 1.18)0.350.99 (0.93 to 1.06)0.88
MV1.04 (0.93 to 1.15)‡‡0.520.99 (0.93 to 1.06)† † 0.84
  • Bold refers to the statistically significant p values.

  • Reference categories of covariate.

  • *Morphological subtype ‘TGA-IVS’.

  • †Male sex. 

  • ‡Tricuspid pulmonary valve. 

  • §No left ventricular outflow tact obstruction. 

  • ¶No previous PAB.

  •   **Age ASO <6 months.

  • ††Multivariable analysis adjusted for morphological subtype, gender, pulmonary valve, previous PAB and age ASO ≥6 months of age.

  • ‡‡Multivariable analysis adjusted for morphological subtype and gender.

  • AR, neo-aortic valve regurgitation; ASO, arterial switch operation; DORV-SP-VSD, double outlet right ventricle with subpulmonary ventricular septal defect; HR, Hazard Ratio; IVS, intact ventricular septum; MV, multivariable analysis; N/A, not applicable; OTO, outflow tract obstruction; PAB, pulmonary artery banding; STJ, sinotubular junction; TGA, transposition of the great arteries; UV, univariable analysis; VSD, ventricular septal defect.